Kaushal Shah, MD, MPH, MBA

Department of Psychiatry, Atrium Wake Forest Baptist Health, Winston-Salem, North Carolina

PCC
Prolonged Delirium After ECT
Case Report

May 20, 2025

The authors present a case of prolonged ECT-associated delirium in a 65-year-old woman, offering insights into the proposed pathophysiology.
, , , et al
PCC
Ketamine-Associated Psychosis After Surgery
Case Report

March 4, 2025

The authors present a unique case of extended postoperative psychosis after intraoperative ketamine induction for analgesia.
, ,
PCC
Factitious Disorder in the Context of Abuse in an Adolescent
Case Report

February 27, 2025

This case illustrates the complexities of diagnosing factitious disorder in adolescents, in which psychosocial factors play a significant role.
, , , et al
PCC
Psychosis With Use of an Herbal Chinese Slimming Product
Case Report

June 11, 2024

A woman with no underlying mood disorder experienced psychotic symptoms after taking an herbal appetite suppressant.
, , , et al
PCC
Camptocormia and Antipsychotic Medications
Brief Report

May 23, 2024

Camptocormia, or “bent spine syndrome,” is an often-overlooked adverse effect of antipsychotics; early diagnosis and treatment is essential to prevent severe consequences.
, , , et al
PCC
Fentanyl-Laced Marijuana Use in Adolescents [Retracted]
Letter to the Editor

February 6, 2024

, , , et al
PCC
Catatonia and Psychosis With Hyperthyroidism
Case Report

November 23, 2023

Catatonia is a rare manifestation of hyperthyroidism. This report describes a case of catatonia and psychosis resulting from hyperthyroidism in a woman with no previous psychiatric history.
, , , et al
PCC
Prescription Bupropion Misuse
Case Report

November 21, 2023

Bupropion is considered a substance of low abuse potential. This report describes a case of bupropion misuse leading to mania in a patient with attention-deficit/hyperactivity disorder.
, , , et al
PCC
Elevated Creatine Phosphokinase and Antipsychotics
Case Report

September 21, 2023

Elevated creatine phosphokinase should not be presumed to be neuroleptic malignant syndrome in patients taking antipsychotics.
, , , et al
PCC
Challenges in the Management of Mania in COVID-19 Patients
Case Series

September 7, 2023

These cases outline the pharmacologic and ethical challenges of managing acute mania in COVID-19 patients.
, , , et al
PCC
Olanzapine-Induced Bradycardia
Case Report

August 15, 2023

A 34-year-old man with history of MDD developed significant bradycardia with olanzapine use.
, , , et al
PCC
New-Onset Psychosis Secondary to COVID-19 Infection
Brief Report

July 13, 2023

Neuropsychiatric complications can develop within weeks of COVID-19 infection and thus should be considered a causative agent of sudden and new-onset psychotic disorders.
, , , et al

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe